Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
Nicole A. Doria‐Rose, Mehul S. Suthar, Mat Makowski, Sarah O’Connell, Adrian B. McDermott, Britta Flach, Julie E. Ledgerwood, John R. Mascola, Barney S. Graham, Bob C. Lin, Sijy O’Dell, Stephen D. Schmidt, Alicia T. Widge, Venkata Viswanadh Edara, Evan J. Anderson, Lilin Lai, Katharine Floyd, Nadine Rouphael, Veronika I. Zarnitsyna, Paul C. Roberts, Mamodikoe Makhene, Wendy Buchanan, Catherine J. Luke, John H. Beigel, Lisa A. Jackson, Kathleen M. Neuzil, Hamilton Bennett, Brett Leav, Jim Albert, Pratap Kunwar
Abstract
Persistence of Antibody after mRNA-1273 Vaccination A total of 33 participants who received both doses of the Moderna mRNA-1273 vaccine against SARS-CoV-2 had blood drawn over a period of 6 months ...
Topics & Concepts
Persistence (discontinuity)Coronavirus disease 2019 (COVID-19)AntibodyVirologyVaccinationMessenger RNASevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineImmunology2019-20 coronavirus outbreakBiologyInternal medicineGeneGeneticsInfectious disease (medical specialty)OutbreakDiseaseEngineeringGeotechnical engineeringSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesHeparin-Induced Thrombocytopenia and Thrombosis